Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

IL-6 mobilizes bone marrow-derived cells to the vascular wall, resulting in neointima formation via inflammatory effects.

Shoji M, Furuyama F, Yokota Y, Omori Y, Sato T, Tsunoda F, Iso Y, Koba S, Geshi E, Katagiri T, Suzuki H, Kobayashi Y.

J Atheroscler Thromb. 2014;21(4):304-12. Epub 2013 Dec 20.

2.
3.

HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9.

Hirata Y, Kurobe H, Higashida M, Fukuda D, Shimabukuro M, Tanaka K, Higashikuni Y, Kitagawa T, Sata M.

Atherosclerosis. 2013 Dec;231(2):227-33. doi: 10.1016/j.atherosclerosis.2013.09.010. Epub 2013 Oct 2.

PMID:
24267232
4.

Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice.

Yajima N, Takahashi M, Morimoto H, Shiba Y, Takahashi Y, Masumoto J, Ise H, Sagara J, Nakayama J, Taniguchi S, Ikeda U.

Circulation. 2008 Jun 17;117(24):3079-87. doi: 10.1161/CIRCULATIONAHA.107.746453. Epub 2008 Jun 9.

5.

Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.

Schäfer K, Schroeter MR, Dellas C, Puls M, Nitsche M, Weiss E, Hasenfuss G, Konstantinides SV.

Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1254-9. Epub 2006 Mar 2.

6.

M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system.

Shiba Y, Takahashi M, Yoshioka T, Yajima N, Morimoto H, Izawa A, Ise H, Hatake K, Motoyoshi K, Ikeda U.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):283-9. Epub 2006 Oct 19.

7.

Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice.

Noels H, Zhou B, Tilstam PV, Theelen W, Li X, Pawig L, Schmitz C, Akhtar S, Simsekyilmaz S, Shagdarsuren E, Schober A, Adams RH, Bernhagen J, Liehn EA, Döring Y, Weber C.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1209-20. doi: 10.1161/ATVBAHA.113.302878. Epub 2014 Apr 10.

8.

Vascular remodeling and mobilization of bone marrow-derived cells in cuff-induced vascular injury in LDL receptor knockout mice.

Xu Y, Arai H, Murayama T, Kita T, Yokode M.

Chin Med J (Engl). 2008 Feb 5;121(3):220-6.

PMID:
18298913
9.

Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.

Krishnamurthy P, Thal M, Verma S, Hoxha E, Lambers E, Ramirez V, Qin G, Losordo D, Kishore R.

Circ Res. 2011 Nov 11;109(11):1280-9. doi: 10.1161/CIRCRESAHA.111.248369. Epub 2011 Sep 29.

10.

High-dose granulocyte-colony stimulating factor promotes neointimal hyperplasia in the early phase and inhibits neointimal hyperplasia in the late phase after vascular injury.

Shoji M, Iso Y, Kusuyama T, Omori Y, Soda T, Tsunoda F, Sato T, Koba S, Geshi E, Kobayashi Y, Katagiri T, Suzuki H.

Circ J. 2008 Nov;72(11):1885-93. Epub 2008 Oct 7.

11.

Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.

Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, Asai J, Tsutsumi Y, Sekiguchi H, Silver M, Wecker A, Bord E, Zhu Y, Kishore R, Losordo DW.

Circulation. 2006 Nov 21;114(21):2261-70. Epub 2006 Nov 6.

12.

Deficiency of Long Pentraxin PTX3 Promoted Neointimal Hyperplasia after Vascular Injury.

Ishino M, Shishido T, Suzuki S, Katoh S, Sasaki T, Funayama A, Netsu S, Hasegawa H, Honda S, Takahashi H, Arimoto T, Miyashita T, Miyamoto T, Watanabe T, Takeishi Y, Kubota I.

J Atheroscler Thromb. 2015;22(4):372-8. doi: 10.5551/jat.26740. Epub 2014 Oct 23.

13.

Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.

Murayama H, Takahashi M, Takamoto M, Shiba Y, Ise H, Koyama J, Tagawa Y, Iwakura Y, Ikeda U.

Cardiovasc Res. 2008 Nov 1;80(2):175-80. doi: 10.1093/cvr/cvn250. Epub 2008 Sep 13.

PMID:
18791204
14.

Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.

Harada N, Ito K, Hosoya T, Mimura J, Maruyama A, Noguchi N, Yagami K, Morito N, Takahashi S, Maher JM, Yamamoto M, Itoh K.

Free Radic Biol Med. 2012 Dec 15;53(12):2256-62. doi: 10.1016/j.freeradbiomed.2012.10.001. Epub 2012 Oct 7.

PMID:
23051009
15.

Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation.

Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Böhm M, Nickenig G.

Circulation. 2003 Jun 24;107(24):3059-65. Epub 2003 Jun 16.

16.

Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.

Zhang LN, Wilson DW, da Cunha V, Sullivan ME, Vergona R, Rutledge JC, Wang YX.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):765-72. Epub 2006 Feb 2.

17.

Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice.

Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, Izawa A, Ise H, Ikeda U.

Cardiovasc Res. 2006 Apr 1;70(1):61-9. Epub 2006 Jan 31.

PMID:
16448633
18.

Heat shock factor 1 contributes to ischemia-induced angiogenesis by regulating the mobilization and recruitment of bone marrow stem/progenitor cells.

Kubo M, Li TS, Kurazumi H, Takemoto Y, Ohshima M, Yamamoto Y, Nishimoto A, Mikamo A, Fujimoto M, Nakai A, Hamano K.

PLoS One. 2012;7(5):e37934. doi: 10.1371/journal.pone.0037934. Epub 2012 May 24.

19.

Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.

Lv L, Zhang J, Wang P, Meng Q, Liang W, Zhang L.

J Vasc Surg. 2014 Feb;59(2):500-9. doi: 10.1016/j.jvs.2013.03.049. Epub 2013 Jun 4.

20.

Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.

Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW, Fazel S, Li RK, Yau TM, Weisel RD, Stanford WL, Verma S.

Circ Res. 2006 Sep 15;99(6):617-25. Epub 2006 Aug 24.

Supplemental Content

Support Center